We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-6 of 6

Legal implications and business considerations for technologies involving human embryonic stem cells in Europe and U.S.

  • Morrison & Foerster LLP
  • -
  • European Union, USA
  • -
  • June 27 2012

The future may be getting brighter for stem cell researchers in the United States as restrictions for funding of stem cell research have been loosened, but efforts to commercialize stem cell technologies have faced a new hurdle with a recent decision by a European court regarding the patentability of human embryonic stem cells

Draft EU regulation on OTC derivatives, central counterparties and trade repositories

  • Morrison & Foerster LLP
  • -
  • European Union, USA
  • -
  • September 20 2010

On 15 September 2010, the European Commission ("EU Commission") tabled its legislative proposal (the "Proposal") for a Regulation on OTC derivatives, central counterparties and trade repositories (the "Regulation"

Compensation for dummies

  • Morrison & Foerster LLP
  • -
  • European Union, USA
  • -
  • March 11 2011

In the aftermath of the financial crisis, regulators in the United States and in Europe have focused on modifying compensation practices at financial institutions

Transatlantic navigation of securitization reforms: a guide

  • Morrison & Foerster LLP
  • -
  • European Union, USA
  • -
  • May 10 2011

The frequency and volume of new securitization regulation being introduced in the US and the EU presents challenges

Focus on ETFsETNs

  • Morrison & Foerster LLP
  • -
  • European Union, USA
  • -
  • November 8 2011

Since our alert in June 2011 concerning the regulatory scrutiny focused on ETFs, the focus has only intensified

EU Regulation on Short Selling: impact on U.S. issuers of structured notes

  • Morrison & Foerster LLP
  • -
  • European Union, USA
  • -
  • November 13 2012

On November 1, 2012, the regulation (the “Regulation”) of the European Parliament and Council of the European Union on short selling and certain aspects of credit default swaps became effective

Current Search

Suggested Facets

Author

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy